[en] A 6-y-old girl with right atrial myxoma presented with remittent fever attacks, general arthralgia and laboratory investigations mimicking rheumatic or autoimmune disease. Interleukin-6 (IL-6) serum concentration was markedly elevated before and normal after tumour resection, whereas myxoma cells stained negatively for IL-6. IL-6 should be considered a myxoma marker: overproduction by myxoma cells and consecutive systemic passage are assumed to cause immunological features.
Marx, G.R., Cardiac tumors (1994) Heart Disease in Infants, Children, and Adolescents, 2, pp. 1773-1786. , Moss and Adams, editors. Baltimore: Williams & Wilkins
Pessotto, R., Santini, F., Piccin, C., Consolaro, G., Faggian, G., Mazzucco, A., Cardiac myxoma of the tricuspid valve: Description of a case and review of the literature (1994) J Heart Valve Dis, 3, pp. 344-346
Bjessmo, S., Ivert, T., Cardiac myxoma: 40 Years's experience in 63 patients (1997) Ann Thorac Surg, 63, pp. 697-700
Meyns, B., Vancleemput, J., Flameng, W., Daenen, W., Surgery for cardiac myxoma. A 20-year experience with long-term follow-up (1993) Eur J Cardio-thorac Surg, 7, pp. 437-440
Wiedermann, C.J., Reinisch, N., Fischer-Colbrie, R., Vollmar, A.M., Herold, M., Knapp, E., Proinflammatory cytokines in cardiac myxomas (1992) J Intern Med, 232, pp. 263-265
Jourdan, M., Bataille, R., Séguin, J., Zhang, X.G., Chaptal, P.A., Klein, B., Constitutive production of interleukin-6 and immunologic features in cardiac myxomas (1990) Arthritis Rheum, 33, pp. 398-402
Kanda, T., Umeyama, S., Sasaki, A., Nakazato, Y., Morishita, Y., Imai, S., Interleukin-6 and cardiac myxoma (1994) Am J Cardiol, 74, pp. 965-967
Parissis, J.T., Mentzikof, D., Georgopoulou, M., Gikopoulos, M., Kanapitsas, A., Merkouris, K., Kefalas, C., Correlation of interleukin-6 gene expression to immunologic features in patients with cardiac myxomas (1996) J Interferon Cytokine Res, 16, pp. 589-593
Soeparwata, R., Poeml, P., Schmid, C., Neuhof, H., Scheid, H.H., Interleukin-6 plasma levels and tumor size in cardiac myxoma (1996) J Thorac Cardiovasc Surg, 112, pp. 1675-1677
Saji, T., Matsuo, N., Shiono, N., Yokomuro, H., Watanabe, Y., Takanashi, Y., Komatsu, H., Serum/tissue interleukin-6 concentrations and constitutional anomalies in 5 patients with cardiac myxoma (1993) Kokyu To Junkan, 41, pp. 891-895
Saji, T., Yanagawa, E., Matsuuru, H., Yamamoto, S., Ishikita, T., Matsuo, N., Increased serum interleukin-6 in cardiac myxoma (1991) Am Heart J, 122, pp. 579-580
Hirano, T., Taga, T., Yasukawa, K., Nakajima, K., Nakano, N., Takatsuki, F., Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production (1987) Proc Natl Acad Sci USA, 84, pp. 228-231
Kanda, T., Sakamaki, T., Murata, K., A cardiac myxoma with interleukin-6 production and cerebral metastasis (1994) Int J Cardiol, 45, pp. 144-146
Séguin, J.R., Beigbeder, J.Y., Hvass, U., Langlois, J., Grolleau, R., Jourdan, M., Interleukin-6 production by cardiac myxomas may explain constitutional symptoms (1992) J Thorac Cardiovasc Surg, 103, pp. 599-600
